文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

和胃汤对慢性萎缩性胃炎及幽门螺杆菌根除的影响

Effect of Hewei-Decoction on chronic atrophic gastritis and eradication of Helicobacter pylori.

作者信息

Ji Wan-Sheng, Gao Zhi-Xing, Wu Kai-Chun, Qiu Jun-Wen, Shi Bing-Long, Fan Dai-Ming

机构信息

Department of Internal Medicine, Weifang Medical College, Weifang 261042, Shandong Province, China.

出版信息

World J Gastroenterol. 2005 Feb 21;11(7):986-9. doi: 10.3748/wjg.v11.i7.986.


DOI:10.3748/wjg.v11.i7.986
PMID:15742401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4250790/
Abstract

AIM: To demonstrate the effect of Hewei-Decoction (Decoction for regulating the stomach) on chronic atrophic gastritis (CAG) and eradication of Helicobacter pylori. METHODS: Ninety patients with CAG entering the investigation were divided into six differentiation syndromes, based on their major symptoms and signs. Hewei-Decoction was taken by all the patients orally for 4 or 8 wk. The efficacy was assessed by both the composite accumulation of reduced scores of major symptoms and the eradication of H pylori. chi(2) test was used to compare the efficacy between H pylori-positive and negative cases, and to disclose the relationship between efficacy and eradication of H pylori. RESULTS: In patients with six different syndrome types, the efficacy of Hewei-Decoction was 91.67% (11/12), 92.86% (13/14), 97.22% (35/36), 87.50% (14/16), 75.00% (6/8), 75.00% (3/4) respectively. The rate of highly efficacious was 58.33% (7/12), 50.00% (7/14), 77.78% (28/36), 62.50% (10/16), 12.50% (1/8) and 25.00% (1/4), respectively. The total efficacy was 91.11% (82/90), and the rate of highly efficacious was 60.00% (54/90). The eradication rate of H pylori was 67.86% (38/56). The therapeutic effect of Hewei-Decoction was better in H pylori positive cases than that in H pylori-negative cases with the total effect of 96.43% vs 82.35% (P<0.05). In 56 H pylori positive cases, the therapeutic effect was better in H pylori eradicated cases than that in H pylori- existent cases with the total effect of 97.37% vs 72.22% (P<0.01). CONCLUSION: Hewei-Decoction is effective in most cases of all the syndrome types. The results indicate that eradication of H pylori is one of the important mechanisms for alleviation of symptoms and signs. Also, the decoction is efficacious in H pylori-negative cases.

摘要

目的:观察和胃汤治疗慢性萎缩性胃炎(CAG)及根除幽门螺杆菌的效果。 方法:将90例纳入研究的CAG患者按主要症状和体征分为六个证型。所有患者口服和胃汤4或8周。通过主要症状积分减少的综合累积情况及幽门螺杆菌的根除情况评估疗效。采用χ²检验比较幽门螺杆菌阳性和阴性病例的疗效,并揭示疗效与幽门螺杆菌根除之间的关系。 结果:六个不同证型患者中,和胃汤的有效率分别为91.67%(11/12)、92.86%(13/14)、97.22%(35/36)、87.50%(14/16)、75.00%(6/8)、75.00%(3/4)。显效率分别为58.33%(7/12)、50.00%(7/14)、77.78%(28/36)、62.50%(10/16)、12.50%(1/8)、25.00%(1/4)。总有效率为91.11%(82/90),显效率为60.00%(54/90)。幽门螺杆菌根除率为67.86%(38/56)。和胃汤对幽门螺杆菌阳性病例的治疗效果优于幽门螺杆菌阴性病例,总有效率分别为96.43%和82.35%(P<0.05)。在56例幽门螺杆菌阳性病例中,幽门螺杆菌根除病例的治疗效果优于幽门螺杆菌未根除病例,总有效率分别为97.37%和72.22%(P<0.01)。 结论:和胃汤对各证型的大多数病例有效。结果表明,根除幽门螺杆菌是缓解症状体征的重要机制之一。此外,该方对幽门螺杆菌阴性病例也有效。

相似文献

[1]
Effect of Hewei-Decoction on chronic atrophic gastritis and eradication of Helicobacter pylori.

World J Gastroenterol. 2005-2-21

[2]
Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.

Hepatogastroenterology. 2003

[3]
[Effects of Xiangsha Liujunzi decoction on TLR signal pathway in gastric mucosa tissues of rats with Helicobacter pylori-induced chronic atrophic gastritis].

Zhongguo Zhong Yao Za Zhi. 2016-8

[4]
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.

Turk J Gastroenterol. 2005-12

[5]
Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis.

Anticancer Res. 2000

[6]
Helicobacter pylori eradication and associated changes in the gastric mucosa.

Expert Rev Anti Infect Ther. 2005-10

[7]
[The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].

Pol Merkur Lekarski. 2008-2

[8]
[Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].

Orv Hetil. 2000-12-10

[9]
Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori.

J Clin Pathol. 1992-9

[10]
Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.

Scand J Gastroenterol. 2002-7

引用本文的文献

[1]
Intestinal Protective Effects of Herbal-Based Formulations in Rats against Neomycin Insult.

Evid Based Complement Alternat Med. 2013-4-11

[2]
An Angiotensin I converting enzyme polymorphism is associated with clinical phenotype when using differentiation-syndrome to categorize korean bronchial asthma patients.

Evid Based Complement Alternat Med. 2011-2-17

本文引用的文献

[1]
Gastric cancer: diagnosis and treatment options.

Am Fam Physician. 2004-3-1

[2]
Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela.

Cancer Epidemiol Biomarkers Prev. 2004-3

[3]
Molecular mimicry between Helicobacter pylori antigens and H+, K+ --adenosine triphosphatase in human gastric autoimmunity.

J Exp Med. 2003-10-20

[4]
Oxidative damage of the gastric mucosa in Helicobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradication.

Helicobacter. 2003

[5]
Association of H. pylori infection with gastric carcinoma: a Meta analysis.

World J Gastroenterol. 2001-12

[6]
Do all patients in primary care who may benefit from eradication of Helicobacter pylori have access to effective care?

Public Health. 2001-7

[7]
Helicobacter pylori and gastroesophageal reflux disease: to treat or not to treat?

Scand J Gastroenterol. 2001-7

[8]
H pylori infection. Review of the guideline for diagnosis and treatment.

Geriatrics. 2000-6

[9]
Current therapy for Helicobacter pylori infection in children and adolescents.

Can J Gastroenterol. 1999-9

[10]
TCM differential treatment of 57 cases of chronic gastritis complicated by ulcerative colitis.

J Tradit Chin Med. 1999-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索